Table 1.
No. of samples positive for each virus | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HCoV-229E | HCoV-OC43 | HCoV-NL63 | HCoV-HKU1 | RSV | RV | HAdV | Flu | PIV | HBoV | HMPV | |
HCoV-229E (n = 86) |
- | 5 | 2 | 0 | 9 | 10 | 12 | 14 | 0 | 2 | 2 |
HCoV-OC43 (n = 624) |
5 | - | 11 | 0 | 126 | 103 | 69 | 25 | 25 | 19 | 7 |
HCoV-NL63 (n = 371) |
2 | 11 | - | 0 | 35 | 46 | 29 | 17 | 13 | 11 | 10 |
HCoV-HKU1 (n = 33) |
0 | 0 | 0 | - | 1 | 6 | 5 | 0 | 1 | 0 | 0 |
All HCoVs (n = 1,096*) |
- | - | - | - | 170† | 163† | 113† | 53† | 39 | 32 | 18† |
Two different types of HCoVs were co-detected in 18 samples.
Due to the samples with ≥2 non-HCoV co-detections, the sum of the number of samples positive for each non-HCoV is greater than the number of samples with any non-HCoV co-detection. RSV, respiratory syncytial virus; RV, Rhinovirus; HAdV, human adenovirus; Flu, influenza; PIV, parainfluenza virus; HBoV, human bocavirus; HMPV, human metapneumovirus.